Medical Marijuana Remains Federally Illegal.. Yet Synthetic Marijuana Has Been Approved by DEA

Why the DEA Supports Synthetic Marijuana but Shuns Organic Marijuana

Ironically, the DEA has agreed to allow a manufacturer of fentanyl to produce synthetic marijuana that is supposedly more medicinally useful than genuine marijuana. What’s even more suspicious—or questionable—is that this company called Insys Therapeutics previously donated $500,000 to prevent marijuana from being legalized in Arizona. Nevertheless, the DEA has approved the manufacture and distribution (with prescription) of the drug Syndros: liquid synthetic THC, a schedule 2 controlled substance. Yet, genuine marijuana will remain classified as a schedule 1 controlled substance alongside drugs like heroine—drugs which are said to have zero medicinal value whatsoever.

Insys founder John Kapoor has already been arrested for bribing doctors and defrauding insurance companies regarding an extremely lucrative fentanyl nasal spray drug that has helped him maintain his billionaire status. Numerous states have lawsuits out against Kapoor and his company for directly causing America’s opioid crisis, which is likely to become the leading cause of death in the United States as a whole unless drastic action is taken to combat it—and its masterminds.

Kapoor’s fentanyl nasal spray is approximately 50 times more potent than heroin, and Kapoor is fully aware that even though marijuana is likely safer and more effective than his drug, acknowledging or accepting these facts would make his lucrative and dangerous drugs worthless.

Kapoor’s scheme worked perfectly: Arizona is the only state that had legalizing marijuana on the ballot in 2016 that didn’t end up with overwhelming support in favor of legalization. However, it’s certainly not the first time that heartless and soulless pharmaceutical companies have funded anti-marijuana propaganda: there’s a reason marijuana still hasn’t been legalized nationwide despite the fact that an overwhelming number of scientists and experts have argued that doing so could easily prevent unnumbered opioid addictions and deaths.

In fact, it’s now known that the CBD component in marijuana is efficient and effective at treating epilepsy. Additionally, it could potentially aid in treating Alzheimer’s disease, Parkinson’s, anxiety, and depression. CBD has been shown to ease inflammation, provide antioxidants, and decrease pain and suffering. All-in-all, modern research argues that marijuana should not be scheduled as an illegal drug at all, let alone as a schedule 1 controlled substance.

Kapoor is out on $1 million bail; Insys President and CEO Saeed Motahari has been handling his PR. It turns out that the drug Syndros is similar to another synthetic THC called Marinol, which was previously approved by the FDA to treat anorexia brought on by AIDS or cancer. Unfortunately, since cannabis is organic and cannot be patented (in general—in some cases, specific strands could be patented), expensive and less-safe alternatives to marijuana will continue to be rammed down the throats and lungs of Americans who would prefer to ingest more healthier and organic alternatives.

Over half the states have already legalized some form of medicinal marijuana, but the FDA will continue to refuse to remove cannabis from the schedule 1 category until the public forces them to do so. If you do not agree with the following statements made on behalf of the DEA, please ensure that your voice and your viewpoint is heard: “two commenters expressed concern that pharmaceutical companies are making a profit from approved drugs containing marijuana constituents. The DEA notes that FDA-approved products of oral solutions containing dronabinol [THC] have an approved medical use, whereas marijuana does not have an approved medical use and therefore remains in Schedule I.”







Leave a Reply

Your email address will not be published.